RE: Future possibilities26 Nov 2021 12:57
"Just like to also highlight CD4 revenues,haven't noticed it mentioned much. Sales in 1st half grew from £12k to £167k , but we already have a firm order book of £800k up to end Oct. to be delivered in the 2nd half..that's excellent growth and helps underpin current valuation.If such a trend were to continue,we could be looking at some very healthy CD4 revenues in coming years."
How does that underpin a market cap of £47 m at current SP of 26p?
odx was only attractive as a covid stock - colin has pretty much blown that. there will be income from DAM but i am afraid even that will not support that kind of mcap. it would have been significant compared to pre covid ODX but not ODX who were awarded a gov contract that they failed to deliver on